Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/1993
12/09/1993WO1993024449A1 Peptidyl derivatives and their use as metalloproteinases inhibitors
12/09/1993WO1993024142A1 New pharmaceutical uses of krill enzymes
12/09/1993WO1993024139A1 Antibiotic cryptdin peptides and methods of their use
12/09/1993WO1993024134A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
12/09/1993WO1993024125A1 Δ-8-tetrahydro-cannabinol as antiemetic
12/09/1993WO1993024124A1 Compositions based on histamine h2-receptor antagonists and cationic exchangers complexes
12/09/1993DE4218096A1 Spiro-oxetane, Verfahren zu ihrer Herstellung und Arzneimittel Spiro-oxetanes, processes for their preparation and pharmaceutical
12/09/1993CA2306952A1 Method for removing dental plaque
12/09/1993CA2136977A1 _-8-tetrahydro-cannabinol as antiemetic
12/09/1993CA2136623A1 Compositions based on histamine h-2 receptor antagonists and cationic exchangers complexes
12/09/1993CA2136349A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
12/09/1993CA2136183A1 Spiro-oxetanes, processes for their production and pharmaceutical agents
12/09/1993CA2114623A1 Sulphamide derivatives as metalloproteinase inhibitors
12/09/1993CA2114622A1 Peptidyl derivatives and their use as metalloproteinases inhibitors
12/08/1993EP0573360A1 Pyrrolothienopyrazine compounds as 5-HT3 receptors antagonists
12/08/1993EP0573221A1 The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
12/08/1993EP0572688A1 Peptides with organo-protective activity, the process for preparing them and their use in therapy
12/08/1993EP0490920B1 Pharmaceutical preparation binding with gastric acid
12/08/1993EP0480983B1 Use of peroxidated lipids for the preparation of medication to be used in the treatment, by local application, of circulation deficiencies
12/08/1993CN1023017C Process for preparing macrolide compositions
12/08/1993CN1023007C Process for preparing pyrrolidine derivatives
12/07/1993US5268360 Opioid peptides derived from wheat proteins
12/06/1993CA2097779A1 New pyrrolothienopyrazinic compounds, process for their preparation and pharmaceutical composition containing them
12/06/1993CA2097766A1 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides
12/01/1993EP0571613A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
12/01/1993CN1022914C Process for preparation of 1, 3-disubstituted piperidine derivatives
11/1993
11/30/1993US5266592 Compositions which have a physiological cooling effect, and active compounds suitable for these compositions
11/30/1993US5266571 Treatment of hemorrhoids with 5-HT2 antagonists
11/30/1993US5266570 Piperidine derivatives, compositions and use
11/30/1993US5266334 Sugar-free dry mix cellulose ether compositions as bulk laxatives
11/30/1993CA2097016A1 Pharmaceutical compounds
11/30/1993CA1324763C Treatment of periodontal disease
11/30/1993CA1324758C Transdermal antisecretory agents for gastrointestinal disease
11/25/1993WO1993023569A1 Method and reagent for inhibiting viral replication
11/25/1993WO1993023428A1 Calcium channel blocking polypeptides from filistata hibernalis
11/25/1993WO1993023395A1 Heteroaromatic quinuclidinenes, their use and preparation
11/25/1993WO1993023391A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993WO1993023069A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
11/25/1993WO1993023043A1 Agent for increasing somatostatin or for inhibiting decrease of somatostatin
11/25/1993WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993CA2135646A1 Method and reagent for inhibiting viral replication
11/25/1993CA2135605A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993CA2112262A1 Agent for increasing somatostatin or for inhibiting decrease of somatostatin
11/24/1993EP0571338A1 Pharmaceutical oral controlled release composition comprising small pellets of bile acids
11/24/1993EP0571219A2 Esterified propoxylated glycerin fat substitute compositions resistant to gastrointestinal side effects
11/24/1993EP0420862B1 Pharmaceutical composition containing deoxyribonucleosides for wound healing
11/24/1993EP0344184B1 Derivatives of (r) 5-pentylamino-5-oxopentanoic acid with anticholecystokinin activity
11/24/1993CN1022830C Preparation of benzamides
11/23/1993US5264216 Treatment of bacterial infections
11/21/1993CA2096152A1 Esterified propoxylated glycerin fat substitute compositions resistant to gastrointestinal side effects
11/19/1993CA2096394A1 Pharmaceutical oral controlled release composition comprising small pellets of bile acids
11/18/1993EP0569493A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
11/18/1993EP0569487A1 Endothelin converting enzyme inhibitors
11/18/1993EP0569396A1 Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion
11/17/1993EP0641217A4 Amylase-electrolyte oral rehydration method and apparatus.
11/17/1993CN1078471A Pharmaceuticals
11/17/1993CN1078469A Substituted indole, azaindole and tetrahydro-1H-pyrrol pyrrolo |2,3-c¨ pyridin-7-one derivatives
11/16/1993US5262419 Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
11/16/1993US5262418 Laxatives, gastrointestinal disorders
11/16/1993US5262169 Tablets and granulates containing mesna as active substance
11/16/1993US5262164 Insertion into or around the tooth cavity the drug monolein mixed with vitamins, antiiinflammatory agents, antibiotics, peroxides, anesthetic agents and microbactericides
11/16/1993CA1324381C Aryl-substituted naphthyridine and pyridopyrazine derivatives
11/11/1993WO1993021992A1 Laser treatment
11/11/1993WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
11/11/1993WO1993021920A1 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
11/09/1993US5260304 Pharmaceutical preparation binding with gastric acid
11/09/1993US5260282 Saliva substitute
11/09/1993US5260279 Enteral nutrition and medical foods having soluble fiber
11/09/1993US5260224 Tissue injury prevention
11/09/1993CA1324143C Quinoline dioic acids and amides
11/03/1993EP0568306A1 Anticonvulsant fructopyranose cyclic sulfites and sulfates
11/03/1993EP0568160A2 Toothpaste
11/03/1993EP0567997A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical
11/03/1993EP0567767A1 Crystalline forms of endo-2,3-dihydro-N-(8-methyl-8-azabicyclo 3.2.1 oct-3-yl)-2-oxo-1H-benzimidazole-1-carboxamide hydrochloride monohydrate and of endo-3-ethyl-2,3-dihydro-N-(8-methyl-8-azabicyclo 3.2.1 oct-3-yl)-2-oxo-1H-benzimidazole-1-carboxamide hydrochloride monohydrate as 5-HT antagonists
11/03/1993EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/03/1993EP0567498A1 Pharmaceutical composition containing granisetron and dexamethasone
11/03/1993EP0357788B1 Pyridazinone derivatives
11/03/1993CN1077960A Hemoregulatory peptides
11/03/1993CN1077952A Carbamate derivatives
11/03/1993CN1022626C Process for preparation of furan derivatives
10/1993
10/31/1993CA2095206A1 4- or 5-(sulf)imido- and -(sulfon)amidopyridines and their pyridine n-oxides, processes for their preparation, and their use as medicaments
10/28/1993WO1993021302A1 Cadherin materials and methods
10/28/1993WO1993021227A1 Tachykinin antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/28/1993WO1993021219A1 Endothelin antagonists ii
10/28/1993WO1993021172A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
10/28/1993WO1993021170A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same
10/28/1993WO1993020826A1 Pharmaceutical composition
10/28/1993WO1993020696A1 Regulation of the immune system
10/28/1993CA2133090A1 Endothelin antagonists ii
10/28/1993CA2130096A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives; process for preparing the same and therapeutic agents containing them
10/28/1993CA2118253A1 Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds
10/27/1993EP0567201A2 Vehicles for oral administration of a specific pharmaceutically active acid labile substance
10/27/1993EP0398893B1 Preparation for dental treatment and method for production of the preparation
10/27/1993EP0329656B1 Active principle isolated from shark tissues
10/27/1993CN1022566C Process for preparation of substituted 1-piperidylalkylene-pyridopyrimidone or thiazolpyrimidone
10/26/1993US5256671 A prodrug as tachykinin antagonists for treating headaches, pain or inflammation
10/20/1993EP0566020A1 Benzimidazoles, pharmaceutical compositions thereof and processes for their preparation
10/20/1993EP0565683A1 Quinoxaline derivates with affinity for quisqualate-receptors
10/20/1993EP0565582A1 Novel csaids
10/20/1993EP0404792B1 Use of sulphated sucrose in preparations for the treatment of teeth and their supporting tissue
1 ... 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 ... 1258